Xu Fuxin, deputy director of Anhui Provincial Food and Drug Administration, and his party visited Huibang Biological Research and Guidance

Date：

2022-02-15

On the morning of February 15 , 2022 , Deputy Director Xu Fuxin, Director Xiong Yongheng, and Director Zhu Dehong of Anhui Provincial Food and Drug Administration visited Huibang Biotech for research and guidance. Huibang Biotech Chairman Wang Zhongliang and others accompanied the reception . A meeting was held in the meeting room.

First of all, Chairman Wang Zhongliang, on behalf of all Huibang employees, expressed a warm welcome to Deputy Director Xu Fuxin and his party, and thanked the Anhui Food and Drug Administration for its care and attention to Huibang Biology .

At the meeting, Chairman Wang Zhongliang introduced the company's development status, especially the achievements and development plans of Huibang Biotech in the field of diagnostic reagent raw materials. Then Deputy Director Xu Fuxin wanted to know the company's feedback and suggestions to the Food and Drug Administration and the difficulties in development. Chairman Wang Zhongliang said that the current state supports innovation, but what should we do after innovation ? How to make innovative products enter clinical application quickly . Deputy Director Xu Fuxin said that the Food and Drug Administration attaches great importance to enterprise feedback, and will conduct serious research on Huibang's problems, and provide relevant suggestions on the spot: to benchmark the Yangtze River Delta, and hope that enterprises can provide relevant materials for the Yangtze River Delta to discuss together . Assist enterprises to solve difficulties in development.

During the symposium, Deputy Director Xu Fuxin said that Huibang Biotechnology has many innovative products and focuses on market segments. At present, it is necessary to focus on how to make innovative products go to the national market. The iteration of IVD products is relatively fast. Everything is market-oriented and seizes development opportunities. .

Finally, Deputy Director Xu Fuxin said that the Anhui Provincial Food and Drug Administration will do a good job in the service work of the enterprise, and wished Huibang Biology to quickly promote the IPO process , and this exchange symposium was successfully concluded.

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.